Understanding how ocular melanoma spreads throughout the body is critical for improving patient care and long-term survival. A retrospective study published in BMJ Open Ophthalmology examined patterns of metastasis in patients with conjunctival melanoma, a rare but serious form of ocular melanoma affecting the surface of the eye.
Researchers analyzed data from 167 patients treated at two German medical centers between 1985 and 2013. Patients were followed for an average of 78 months, providing valuable long-term insights into the progression of conjunctival melanoma. The average age at diagnosis was 63 years, and most tumors were initially classified as cT1 stage tumors, typically located on the bulbar conjunctiva.
During the study period, local recurrence occurred in 47% of patients, highlighting the persistent risk of tumor regrowth even after treatment. Overall, 25% of patients developed metastatic disease, emphasizing the importance of careful monitoring following the initial diagnosis of ocular melanoma.
The study found that regional lymph node metastasis often occurred before distant metastasis, suggesting a sequential pattern of disease spread. Regional lymph node involvement occurred in 31 patients at an average of 49 months after diagnosis, while distant metastases—often spread through the bloodstream—developed in 24 patients at an average of 56 months.
Tumor characteristics played a significant role in predicting metastatic risk. Early-stage tumors (cT1) located on the bulbar conjunctiva were associated with lower rates of metastasis. In contrast, cT2 tumors, particularly those involving areas such as the caruncle, fornix, or tarsal conjunctiva, carried a significantly higher risk of spreading. Multifocal tumors were also linked to increased risk of both lymphatic and distant metastasis.
Treatment approaches also influenced outcomes. The study found that pT1 tumors treated with excision alone had similar metastatic risk to more advanced tumors, whereas those treated with adjuvant therapies, including Ruthenium-106 brachytherapy, showed a reduced risk of distant spread.
These findings reinforce the importance of early detection, careful staging, and ongoing surveillance in ocular melanoma patients. By better understanding how conjunctival melanoma spreads, physicians can improve risk stratification and develop more effective follow-up strategies to detect metastasis earlier.
Although the study was limited by its retrospective design and long timeframe, it provides valuable insights into metastatic patterns in ocular melanoma, helping guide future research and clinical care.